PALO ALTO, Calif., Jan. 5, 2011 /PRNewswire/ — Jazz
Pharmaceuticals, Inc. (Nasdaq:
JAZZ) announced today that the company will make a presentation
at the J.P. Morgan Healthcare Conference in San Francisco on
Wednesday, January 12, 2011 at 2:00 p.m. Pacific Time/ 5:00 p.m.
Eastern Time. Bruce Cozadd, the company’s chairman and chief
executive officer, will provide a business and financial
update.
A live webcast of the presentation may be accessed from the
Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.
Please connect to the website prior to the start of the conference
call to ensure adequate time for any software downloads that may be
necessary to listen to the webcast.
An archived version of the webcast will be available for at
least one week on the Investors section of the company’s website at
www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq:
JAZZ) is a specialty pharmaceutical company that identifies,
develops and commercializes innovative treatments for important,
underserved markets in neurology and psychiatry. For further
information see www.jazzpharmaceuticals.com.
‘/>”/>
